Atezolizumab Interactions
There are 622 drugs known to interact with atezolizumab, along with 13 disease interactions. Of the total drug interactions, 25 are major, and 597 are moderate.
- View all 622 medications that may interact with atezolizumab
- View atezolizumab disease interactions (13)
Most frequently checked interactions
View interaction reports for atezolizumab and the medicines listed below.
- Activated Charcoal (charcoal)
- Aspirin Low Strength (aspirin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Colace (docusate)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- Iodides (sodium iodide)
- Iron Sulfate (ferrous sulfate)
- Lenvima (lenvatinib)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Nexium (esomeprazole)
- NovoLog Mix 70/30 FlexPen (insulin aspart/insulin aspart protamine)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- Prilosec (omeprazole)
- Quercetin (bioflavonoids)
- Spiriva Respimat (tiotropium)
- Taxol (paclitaxel)
- Toprol-XL (metoprolol)
- Tums Regular Strength (calcium carbonate)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Xyzal Allergy 24HR (levocetirizine)
Atezolizumab disease interactions
There are 13 disease interactions with atezolizumab which include:
- endocrinopathies
- hepatitis
- infections
- meningitis
- neuropathy
- pancreatitis
- colitis
- liver disease
- pneumonitis
- renal impairment
- HSCT
- myasthenia gravis
- organ transplant
Report options
QR code containing a link to this page
More about atezolizumab
- atezolizumab consumer information
- Compare alternatives
- Reviews (6)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
